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Abstract 
Liver regeneration is usually attributed to mature hepatocytes, which possess a remarkable 
potential to proliferate under mild to moderate injury. However, when the liver is severely 
damaged or hepatocyte proliferation is greatly inhibited, liver stem/progenitor cells (LSPCs) will 
contribute to the liver regeneration process. LSPCs in the developing liver have been extensively 
characterized, however, their contributing role to liver regeneration has not been completely 
understood. In addition to the restoration of the liver parenchymal tissue by hepatocytes or/and 
LSPCs, or in some cases bone marrow (BM) derived cells, such as hematopoietic stem cells (HSCs) 
and mesenchymal stem cells (MSCs), the wound healing after injury in terms of angiopoiesis by 
liver sinusoidal endothelial cells (LSECs) or/and sinusoidal endothelial progenitor cells (SEPCs) is 
another important aspect taking place during regeneration. To conclude, liver regeneration can be 
mainly divided into three distinct restoring levels according to the cause and severity of injury: 
hepatocyte dominant regeneration, LSPCs mediated regeneration, extrahepatic stem cells 
participative regeneration. In this review, we focus on the recent findings of liver regeneration, 
especially on those related to stem/progenitor cells (SPCs)-mediated regeneration and their 
potential clinical applications and challenges. 
Key words: liver stem/progenitor cells (LSPCs); sinusoidal endothelial progenitor cells (SEPCs); mesenchymal 
stem cells (MSCs); hematopoietic stem cells (HSCs); liver regeneration 
Introduction 
The liver has an enormous capacity to regenerate 
through different cellular responses depending on the 
nature and severity of the injury [1]. The whole 
process of liver repair can be integrated into two 
aspects including regeneration and wound healing 
[2]. In other words, in the context of liver injury, 
successful repair consists of both efficient 
parenchymal restoration and appropriate 
angiogenesis which are sufficient to promote liver 
regeneration in most cases [3]. Both aspects are 
modulated by a dynamic interplay between 
parenchymal and non-parenchymal cells, including 
hepatocytes [4], hepatic stellate cells [5, 6], 
inflammatory cells [7], cholangiocytes [8], and liver 
sinusoidal endothelial cells (LSECs) [9, 10]. Therefore, 
defining the multi-cellular crosstalk that balances 
regeneration and dysfunctional healing holds promise 
to design new treatments for liver diseases.  
Liver regeneration is a relatively complex 
process and requires the coordinated contribution of 
different cell types [4]. Generally speaking, due to 
different liver injuries, liver regeneration can be 
mainly divided into three distinct restoring levels [11]. 
Under normal conditions, or after moderate loss of 
parenchyma by surgical resection, liver mass is 
maintained by division of hepatocytes [12, 13].  In 
addition to mature intrahepatic cells, resident and 
migrating stem/progenitor cells (SPCs) also actively 
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participate in liver regeneration. For example, 
activation of liver stem/progenitor cells (LSPCs) is 
widely identified in both acute and chronic injuries 
[14, 15]. When hepatocyte proliferation is inhibited or 
overwhelmed, liver injury leads to the activation of 
LSPCs to replace the injured hepatic parenchyma [14, 
15]. Hepatic oval cells (HOCs) and small 
hepatocyte-like progenitor cells (SHPCs) are two of 
the LSPC populations that have the capacity to 
differentiate into both hepatocyte and cholangiocytes 
[16]. HOCs or SHPCs rapidly proliferateand 
differentiate into hepatocytes and cholangiocytes to 
compensate for the cellular loss and maintain liver 
homeostasis. In addition to intrahepatic SPCs, bone 
marrow (BM) derived SPCs can also contribute to 
liver regeneration by the fusion of mesenchymal stem 
cells (MSCs) with damaged hepatocytes, or 
differentiation into hepatocyte-like cells [17]. In this 
review, we aimed to briefly introduce the proved 
mechanism involving in liver regeneration, especially 
the contributing responses of SPCs.  
 
The contributing roles of LSPCs 
participating in liver regeneration 
The proof for LSPCs participating in liver 
regeneration 
LSPCs are very different from tissue-resident 
stem cells in other epithelial tissue such as intestine 
and skin [18]. In the latter tissues, SPCs are required 
throughout life to replenish cells lost daily, and 
without continued replication of the tissue-resident 
stem cells, the epithelia of intestine and skin fail 
rapidly. In contrast, LSPCs are “facultative,” meaning 
[19] (1) they are not needed to fill up liver tissue under 
normal, healthy conditions and (2) many markers of 
LSPCs are only expressed in the liver after injury 
when SPCs are activated. In severely damaged livers 
when there is a massive loss and/or an inhibited 
proliferative capacity of hepatocytes, activation of 
resident LSPCs occurs to contribute to regeneration 
[19]. When activated, LSPCs migrate into the hepatic 
lobules and differentiate into hepatocytes or 
cholangiocytes to support or take over the role of 
regeneration [14, 15].  
The localization and isolation of 
LSPCs 
LSPCs reside in the terminal 
branches of the intrahepatic biliary tree 
(Canal of Hering) in normal liver 
(Figure 1A) [20]. Recently, using 
Wnt-responsive gene Axin2 in mice, 
Wang et al. identify a population of 
LSPC-like cells adjacent to the central 
vein in the liver lobule [21]. During 
liver injury and repair process, some 
LSPCs also appear scattered in the 
parenchyma. However, the lack of 
highly specific markers has hampered 
efforts to better understand the origin 
and physiology of LSPCs [22]. Here we 
only briefly describe the potential 
markers used to detect or isolate 
LSPCs (Figure 1B), which is 
systematically described in our 
previous review [23]. For sorting 
LSPCs, the following markers have 
been demonstrated effective, 
c-Kit-/low [24], c-Kit-c-Met+CD49f+/ 
low [25], CD13+ [26], 
CD13+c-Kit-CD49f-/lowCD133+ [27], 
or CD24+CK19+ [28] in combination 
with the non-hematopoietic marker 
CD45-TER119-. This CD24+ 
CK19+CD45-Ter119- cell population 
represented 0.04% of liver cells and 
 
Figure 1. The localization and cell surface markers for liver stem/progenitor cells 
(LSPCs). (A) So far, the origin of LSPCs is still not clear. Nevertheless, there is a widely accepted 
theory that LSPCs are derived from the canal of Hering, where the putative “resident” stem cells 
aggregate as the exact cell of origin. In addition, upon certain types of injury condition, LSPCs may 
expand and scatter in the liver parenchyma. (B) The representative intracellular and surface markers 
among species are shown. For human beings, rats and mice, LSPCs share some markers, however, 
there are differently expressed cell markers among different species. The most compelling markers 
potentially useful for isolation of LSPCs in different species, are shown. 
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expressed several markers of LSPCs, such as CD133, 
Dlk, and Sca-1 high, but c-Kit, Thymus cell antigen-1 
(Thy-1), and CD34 low. In liver damage condition, 
single cell marker is also widely used to screen LSPCs. 
For example, it is demonstrated that Lgr5 
((leucine-rich-repeat-containing G-protein-coupled 
receptor 5)+ small cells near bile ducts actively take 
part in the liver regeneration after damage by 
generating significant numbers of hepatocytes and 
biliary duct cells [29]. 
The experimental models for mobilization of 
LSPCs 
Partial hepatectomy (PHx) is considered as a 
classical model for studying liver regeneration in 
mammals [14]. In those damaged livers where 
hepatocyte proliferation is compromised, LSPCs are 
activated and differentiate into hepatocytes and 
cholangiocytes, leading to functional recovery of the 
organ. In humans, a minimum of 50% hepatocyte loss 
is required for significant activation of the LSPC 
compartment [19], and there is an inverse correlation 
between the number of LSPCs and the number of 
proliferating hepatocytes with Ki67 expression [30]. 
This suggests that a combination of hepatocyte loss 
and impaired hepatocyte proliferation is required to 
activate LSPC. For stimulating LSPCs to participate in 
liver regeneration in rodents, a number of models 
have been applied (Figure 2). The most popular model 
to induce LSPCs is the combination of PHx with 
chemical inhibition of hepatocyte proliferation using 
2-acetylaminofluorene (2-AAF) or retrorsine in rats, 
where hepatocyte proliferation is blocked by 2-AAF 
before and after PHx while inducing a robust LSPCs 
response [31, 32]. However, in mice this system is not 
applicable because it fails to produce convincing 
activation of LSPCs, instead, several other dietary or 
toxin models of LSPC activation have been described. 
In short, the administration of a 3,5-diethoxycarbonyl- 
1,4-dihidro-collidine (DDC)-containing diet [33, 34] or 
a choline-deficient, ethionine-supplemented (CDE) 
diet [34, 35] is the most extensively used model for 
activating LSPCs. 
The possible mechanisms responsible for 
LSPCs mediated liver regeneration 
The LSPC response can be divided into four 
phases: activation, proliferation, migration and 
differentiation (Figure 3), the final step leading to 
either hepatocytes or cholangiocytes. The LSPC niche 
comprises the parenchymal and non-parenchymal 
resident liver cells, recruited inflammatory cells, 
extracellular matrix (ECM) as well as the variety of 
growth-regulating factors [14, 33, 36-38], which 
together control the LSPC response to liver 
regeneration.  
The affecting cells of LSPC response in liver 
regeneration 
The LSPC niche is composed of a large variety of 
cell types (Figure 3A) such as hepatic stellate cells, 
LSECs, hepatocytes, cholangiocytes, Kupffer cells, pit 
cells and inflammatory cells [39]. All these cell types, 
numerous hormones and growth factors could 
interact and cross-talk with LSPCs influencing their 
proliferative and differentiative processes (Figure 3B). 
For instance, macrophages and T-cells have been 
shown to interact with LSPCs to regulate 
proliferation, differentiation, and migration of LSPCs 
[40-42], while hepatic stellate cells or myofibroblasts 
have also been observed in close proximity of LSPCs 
both in mouse [43] and in patients with liver diseases 
[44]. The hepatic stellate cells are major resident 
non-parenchymal liver cells [45]. During the early 
 
Figure 2. Two modes of LSPCs mediated liver regeneration in rats and mice. Both in rats and in mice, partial hepatectomy (PHx) is applied to cause liver 
injury for the remaining tissue to enlarge and recover the original mass. This type of regeneration is mainly accomplished by mature hepatocytes in the remaining 
tissue. When PHx combines with the impaired proliferative capacity of hepatocytes by treatment with 2-acetylaminofluorene (2-AAF)-containing diet in rats and 
3,5-diethoxycarbonyl-1,4-dihidro-collidine (DDC)-containing diet or a choline-deficient, ethionine-supplemented (CDE) diet in mice, immature LSPCs are activated 
and contribute to the regeneration process by differentiating to hepatocytes and cholangiocytes. 
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period of liver regeneration (2-6 days after injury), it 
was found that hepatic stellate cells secreted high 
levels of hepatocyte growth factor (HGF) and 
stimulated LSPC proliferation via extracellular 
signal-regulated kinase and p38 pathway, whereas in 
the terminal phase of liver regeneration (12 and 15 
days group) hepatic stellate cells generated high 
levels of transforming growth factor (TGF)-β1, which 
in turn suppressed LSPCs’ DNA synthesis. These 
results indicate that hepatic stellate cells have the dual 
role of promoting and inhibiting LSPCs proliferation 
during the liver regeneration process [46], act as a 
positive regulator at the early phase and a negative 
regulator at the terminal phase of the LSPC-mediated 
liver regeneration. The shift between these two 
distinct effects depends on the balance between HGF 
and TGF-β1 secreted by hepatic stellate cells.  
In addition, it has been demonstrated that 
Thy-1+ mesenchymal cells are also part of the LSPCs 
niche [47, 48]. In all models of LSPC-mediated liver 
regeneration they proliferate quickly and expand 
significantly and disappear from the liver when the 
LSPC response subsides. Activated Thy-1+ cells do 
not express LSPC genes but they express other genes 
(CD105, CD73, CD29) known to be expressed in 
MSCs, genes considered specific for activated hepatic 
stellate cells (desmin, collagen I-α2, matrix 
metalloproteinases (MMP)2, MMP14) and 
myofibroblasts [alpha smooth muscle actin 
(alpha-SMA), fibulin-2], as well as growth factors and 
cytokines (HGF, tumor necrosis factor (TNF)-like 
weak inducer of apoptosis (TWEAK), interleukin 
(IL)-1β, IL-6, IL-15) that can affect LSPC growth [47, 
48].  
The stimulating factors in ECM promoting LSPC 
response in liver regeneration 
In addition to the cross talking among cells in the 
LSPC niche, ECM can also be a factor that regulates 
LSPC activity and function [38, 49-51]. Recent studies 
have shown a requirement for matrix remodeling by 
MMPs for the proliferation of LSPCs [52]. What’s 
more, in ECM, a range of growth factors [33, 34] 
including HGF, epidermal growth factor (EGF), 
TGF-α and stem cell factor (SCF) have been shown to 
be important in stimulating LSPCs growth, whereas 
TWEAK/Fibronectin (FN) 14 and stromal-derived 
factor 1/CXC receptor 4 (SDF-1/CXCR4) have been 
shown to be important for their activation and 
migration respectively. Multiple cytokines are 
involved in the activation and proliferation of LSPCs 
(Figure 3B). These cytokines include TNF [42], 
lymphotoxin alpha [53], lymphotoxin beta [54], 
interferon gamma (IFN-γ) [54], IL-22 [55], and IL-6 
[56]. Two growth factors, fibroblast growth factor 
(FGF)7 [47] and granulocyte-colony stimulating factor 
(G-CSF) [57], have been proposed to act as mitogens 
for LSPCs. Among these cytokines and growth 
factors, HGF is considered to be the important. 
HGF/c-Met supports a pleiotrophic signal 
transduction pathway that controls LSPCs 
homeostasis [33]. Loss of c-Met receptor decreases the 
sphere-forming capacity of LSPCs in vitro and 
reduces LSPC pool, impaires migration, and decreases 
hepatocytic differentiation in vivo. These results 
establish a direct contribution of c-Met in the 
regulation of LSPC response and support a unique 
role for HGF/c-Met as an essential 
growth-factor-signaling pathway for regeneration of 
diseased liver. Another key regulatory mechanism for 
LSPC response is EGF/EGF receptor (EGFR). Both 
HGF/c-Met and EGF/EGFR collaborate to increase 
 
Figure 3. The impact of LSPC-niche on LSPCs mediated liver regeneration. The LSPCs mediated liver regeneration involves four consecutive 
processes including activation, proliferation, migration and differentiation into hepatocytes and cholangiocytes. Thy-1 positive cells play a critical role in each step 
of LSPCs reaction by producing cytokines or intercellular crosstalk. Among those cells affecting LSCPs response, LSECs and SEPCs are very important, because 
they not only take responsibility for vasiformation, but also contribute to major HGF production. In addition, hepatic stellate cells and macrophages can send 
signals directly to stimulate LSPCs response to liver injury. 
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the self-renewal capacity of LSPCs through activation 
of the extracellular signal-regulated kinase pathway 
(ERK) [58]. The c-Met is a strong inducer of 
hepatocyte differentiation by activating protein kinase 
B (PKB or AKT) and signal transducer and activator of 
transcription (STAT3). Conversely, EGFR selectively 
induced Notch1 to promote cholangiocyte 
specification and branching morphogenesis while 
concomitantly suppressing hepatocyte commitment.  
The inflammatory infiltrate may also provide 
paracrine signals from growth and chemotactic 
factors to initiate the regenerative response. 
Potentially important elements of the inflammatory 
response that may stimulate LSPCs include IL-6 
family [leukaemia inhibitory factor (LIF) and 
oncostatin M (OSM)], lymphotoxin-beta, IFN-γ and 
TNF superfamily including TNF-alpha and TWEAK 
[19]. One of the best-established cytokines among 
these is TWEAK, which is produced by macrophages 
and has great paracrine effect on LSPCs activation and 
expansion [59-62].  
The underlying signaling pathways during LSPC 
response in liver regeneration 
LSPCs mediated liver regeneration is followed 
by a series of events involving multiple signaling 
pathways controlled by the previously mentioned 
growth factors and their receptors. The involvement 
of Wnt, Notch and Hedgehog (Hh) signalling 
pathways in LSPCs activation in humans has also 
been reported recently [63, 64]. Activation of Notch 
and Wnt pathways by the surrounding niche has been 
shown to play a critical role in the determination of 
LSPCs to hepatocytic and cholangiocytic fates [23, 40, 
65]. There are results implying that the Wnt pathway 
is involved in directing LSPCs toward the hepatocytic 
fate, while the Notch pathway promotes 
differentiation of LSPCs toward the biliary lineage 
[23, 40, 66]. The Notch ligand Jagged1, generated by 
Thy1+ fibroblasts, acts on the Notch receptor 
expressed on LSPCs to activate the downstream 
signaling pathway, leading to differentiation of LPCs 
to cholangiocytes [40]. In contrast, the canonical Wnt 
molecule acts on LSPCs to induce beta-catenin 
signaling and expression of a Notch signal inhibitor, 
Numb. This eventually results in suppression of the 
default Notch signaling for biliary differentiation in 
LSPCs and, in turn, stimulates their differentiation to 
hepatocytes [40]. In addition, as the Wnt target gene, 
Lgr5 marks actively dividing stem cells in liver 
regeneration. In fact, Lgr5+ small cells can give birth 
to both hepatocytes and biliary duct cells during the 
repair phase [29]. Thus, the balance between two 
distinct niche structures with different signals is 
critical to shape the outcome of activated LSPCs to 
induce proper regenerative response according to the 
nature of liver injury. As a upstream functional 
important effector of Notch-signaling pathway, 
Hippo pathway signaling in vivo is sufficient to 
differentiate LSPCs into hepatocytes [67]. 
The remaining questions and perspectives in 
LSPC mediated liver regeneration 
The pertinent activation of LSPCs is safe and 
necessary to help restoring severely damaged liver, 
however, whether LSPCs could be over-activated and 
impair normal liver regeneration remains unclear. 
Recently, it has been demonstrated that repeated 
LSPC reactions are not necessarily carcinogenic [20]. 
That is to say, the expansion of LSPC compartment 
conceptually can be used to facilitate liver 
regeneration without an increased risk of 
tumorigenesis. 
The utilization of LSPCs for cell therapy is an 
attractive alternative to organ transplantation for the 
treatment of liver disease. There are several 
advantages to using LSPCs instead of primary 
hepatocytes or whole organ transplantation. First, a 
single LSPC can be expanded in culture without 
losing its bidirectional differentiation potential [68]. 
Second, the fact that LSPCs are found in the liver with 
various types of disorders suggests that LSPCs can be 
isolated from diseased livers that cannot be used for 
organ transplantation [69]. Third, it might be possible 
to isolate LSPCs from a patient who has liver disease, 
expand them in culture, and transplant back to the 
patient. This autologous transplant protocol would 
obviate the need for immunosuppression after 
transplantation. Finally, LSPCs are smaller than 
hepatocytes, and it has been suggested that smaller 
cells might have less of a tendency to cause portal 
hypertension following injection into the portal vein. 
In short, isolation and transplantation of LSPCs could 
represent a new approach for therapy of end-stage 
chronic liver diseases, as they offer many advantages 
to transplantation of mature hepatocytes.  
The contributing roles and mechanisms 
for SEPCs participating in liver 
regeneration 
The contribution of LSECs in aiding liver 
regeneration 
Liver regeneration requires spatiotemporally 
precisely coordinated proliferation of the two major 
liver cell populations, hepatocytes and LSECs, to 
reconstitute liver structure and function [70]. LSECs 
control liver regeneration in a much more dynamic 
manner through stimulatory and inhibitory effects. 
LSECs support hepatocytes in resting liver and 
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proliferate during liver regeneration to revascularize 
regenerated liver parenchyma [9]. In the early phases 
of physiological liver regeneration, inhibitor of 
DNA-binding protein (Id)1 mediates inductive 
angiogenesis in LSECs through producing angiocrine 
factors Wnt2 and HGF, which provokes hepatic 
proliferation [71]. Notably, there is a counterbalance 
between activation of CXCR7-Id1 pathway in LSECs 
and CXCR4 upregulation after chronic injury. When 
CXCR7-Id1 pathway overwhelms CXCR4 pathway, it 
leads to normal liver regeneration. In contrast, after 
iterative stimuli, predominance of CXCR4 
upregulation over CXCR7-Id1 activation causes 
fibrosis [2]. Collectively, these data shed fundamental 
insights into the role of the endothelium as a 
gatekeeper and regulator of liver regeneration [70].  
The contribution of sinusoidal endothelial cell 
progenitor cells (SEPCs) in restoring injured 
liver 
 Recent studies indicate that not LSECs but 
SEPCs express more HGF and played more important 
roles in liver regeneration [10, 72]. Two populations of 
SEPCs have been identified: BM SEPCs and resident 
or intrahepatic SEPCs (Figure 4) [9, 10, 73]. Within the 
liver, a putative resident SEPC population has been 
identified based on its characteristics as a 
label-retaining cell. Although the logical function for 
the resident SEPCs would be to give rise to LSECs in 
normal turnover, such functionality has yet to be 
demonstrated. Both resident and BM SEPCs are 
positive for the progenitor cell marker CD133 and, 
like the LSECs, they express the endothelial cell 
marker CD31 and the hematopoietic cell marker CD45 
[9], also positive for vascular endothelial growth 
factor (VEGF) receptor (VEGFR)1 and VEGFR2. After 
both toxic injury and PHx, hepatic VEGF has been 
shown to regulate each step of BM SEPC recruitment 
to the liver: proliferation of BM SEPCs, mobilization 
of BM SEPCs to the circulation, engraftment of BM 
SEPCs in the liver, and differentiation of BM SEPCs to 
fenestrated LSECs lining the sinusoids [9, 10, 73]. 
After PHx or toxic injury, proliferation of BM 
SEPCs increases more than two-fold and mobilization 
of BM SEPCs to the circulation increases two- to 
four-folds [9]. Thus, the BM SEPC response is a repair 
response to disparate forms of liver injury. It is 
believed that BM SEPCs that have been recruited to 
the liver, rather than mature LSECs, are the major 
drivers of liver regeneration (Figure 4) [10]. 
Compared to the resident SEPCs mainly contributing 
to normal LSEC turnover in the liver [10], BM SEPCs 
proliferation and mobilization to the circulation 
doubled and differentiated into fenestrated LSECs 
comprising one-quarter of the total LSECs after liver 
injury. What’s more, BM SEPCs that engraft in the 
liver proliferate much more than resident SEPCs and 
are the major source of increased HGF in the LSEC 
fraction [9]. It seems that when present in their niche, 
resident SEPCs play a lesser role in LSEC 
repopulation after liver injury than BM SEPCs (Figure 
4). However, when resident SEPCs are isolated from 
the liver and infused after PHx, there is marked 
expansion of the SEPCs with persistent engraftment 
as LSECs and SEPCs. In addition, whether the mature 
LSEC also proliferates or whether all of the 
proliferation is attributable to resident and BM SEPCs 
remains to be determined. To summarize, after liver 
injury, BM SEPCs mainly 
repopulate the sinusoid 
as LSECs providing HGF 
to promote hepatocyte 
restoration [74].  
 
Figure 4. The contributing roles 
of SEPCs during liver 
regeneration. There are two types 
of SEPCs including bone marrow 
derived SEPCs (BM SEPCs) and 
resident SEPCs existing in the liver. 
Under VEGF stimulation, BM SEPCs 
obtain increased proliferation, 
mobilize into circulation, and 
transplant in remaining liver tissue to 
help restoration. The recruitment of 
SEPCs from bone marrow are more 
likely to replenish LSECs for 
vasiformation than resident SEPCs. 
What’s more, BM SEPCs not resident 
SEPCs mainly secreting cells of HGF. 
The HGF released by SEPCs and 
LSECs is the key factor for LSPCs or 
hepatocytes responses. 
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The contributing roles and mechanisms 
for other BM stem cells participating in 
liver regeneration 
The contribution to liver regeneration from 
different kinds of extrahepatic stem cells migrating to 
the injured liver such as HSCs and MSCs has been 
previously demonstrated [75]. BM HSCs are 
mobilized after liver resection, limit IL-1β signaling 
mediated inflammation, and boost regeneration in a 
CD39-dependent manner [76]. Due to their great 
contribution in liver repair, currently available HSCs 
mobilizing agents (G-CSF, Plerixa or G-CSF+Plerixa), 
were comparatively tested for healing potential in 
liver fibrosis [77]. In comparison to BM HSCs, BM 
MSCs exhibit a greater homing capability for the 
injured liver and modulate fibrosis and inflammation 
more effectively [78]. However, synergistic effects of 
MSCs and HSCs were not observed in liver injury.  
Among immune regulating cells, both MSC and 
T regulatory (Treg) cells have been considered as 
possible therapeutic agents due to their ability to 
suppress inflammation, which is seen in many forms 
of chronic liver injury [79]. MSCs participate in liver 
regeneration in several different aspects (Figure 5). (1) 
MSCs help restore injured liver mass through 
paracrine factors: CXCR4 overexpression enhanced 
the mobilization and engraftment of MSCs into 
small-for-size liver grafts, in which these cells 
promoted the early regeneration of the remnant liver 
perhaps by a paracrine mechanism [80]. (2) MSCs 
release exosomes to initiate protective responses: 
Recently, MSC-conditioned medium (MSC-CM) 
containing exosomes has been shown to have 
protective effects against various liver injury models. 
MSC-derived exosomes can elicit hepatoprotective 
effects against injury, mainly through activation of 
proliferative and regenerative responses [81]. (3) 
MSCs could trans-differentiate into hepatocytes under 
certain inductive conditions: It has been hypothesized 
that under the influence of liver-regenerating cues, 
BM-MSCs can directly differentiate into hepatocytes 
[82]. (4) MSCs have the power to stimulate VEGF 
generation for vasiformation: BM-MSCs have been 
reported to facilitate liver regeneration after toxic 
injuries and massive hepatectomy, possibly by 
upregulating the level of VEGF [83]. (5) MSCs 
regulate inflammatory reaction after liver injury: 
MSCs promote liver repair by systemically 
concomitant mechanisms involving 
hypoxia-inducible factor-1alpha (HIF-1α) and 
autophagy [84].  
 
 
Figure 5. Schematic depicting the contributions of MSCs to liver regeneration. Liver injury induces proliferation and migration of MSCs. The recruitment 
of MSCs in the liver in turn actively participate in liver regeneration in several different ways: paracrine effective factors, release exosomes to initiate protective 
responses, trans-differentiate into hepatocytes, stimulate vasiformation, regulate inflammatory reaction. 
 
Problems and perspectives 
Remaining questions 
Although the contributing roles of different 
types of SPCs have been greatly elucidated in liver 
regeneration and summarized in this review, the 
underlying detailed mechanism is still far from clear. 
There are several fundamental and critical issues 
concerning SPCs involved in liver regeneration that 
need to be addressed. First of all, the identification 
and isolation of SPCs remains a challenge. In spite of 
some potential markers being used to detect or isolate 
SPCs in the liver, there are some variations among 
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species, especially for LSPCs. In addition, the existing 
markers are not specific enough for investigating 
subsets of SPCs, such as SEPCs. Moreover, the 
localization and origination of most SPCs is waiting to 
be thoroughly investigated. Secondly, the complete 
function of SPCs involved in stem cell mediated liver 
regeneration is pending to be explained: it is not clear 
if they restore damaged liver mass by differentiation 
into parenchymal or non-parenchymal liver cells, or 
by promoting regeneration and reducing damage via 
secreting cytokines/growth factors. Thirdly, the 
activating order of both intrahepatic stem cells and 
extrahepatic stem cells needs to be clarified, thus we 
can make these stem cells coordinate well and 
orchestrate liver regeneration. Last but not the least, it 
is imperative to determine the cross-talk among all 
these SPCs including LSPCs, SEPCs, MSCs and HSCs. 
When the above mentioned questions are totally 
answered, a proper liver regeneration could be 
achieved, without having the risk of over or deficient 
restoration that could lead to fibrosis or liver failure 
respectively.  
Potential perspectives 
Two broad strategies have been employed to 
enhance liver regeneration: (i) administration of 
stimulating factors such as G-CSF to enhance 
endogenous SPCs regeneration and (ii) infusions of 
exogenous SPCs to drive regeneration. In light of the 
current results, improvement of these therapies may 
require the co-infusion of hepatocytes/LSPCs with 
SECs/SEPCs. Moreover, the administration of 
autologous or allogeneic HSCs or/and MSCs can 
augment liver repair by either stimulating 
endogenous repair mechanisms or by suppressing 
ongoing damage. In addition, combining liver cells 
with a mimetic scaffold is also very promising [85]. 
As an attractive technique for scaffold 
preparation, decellularization can guarantee the 
resulting material possible to retain the liver 
architecture, native vessel network and specific ECM 
[85]. Because the SPCs-based therapies are critically 
dependent on the appropriate lineage differentiation 
of the SPCs with a high efficiency and on a 
considerable scale, decellularized liver bio-scaffold 
may provide a three-dimensional extracellular matrix 
for the lineage restriction of SPCs maturation. Thus, 
functional SPCs composite decellularized scaffolds is 
promising to reconstruct liver tissue. Since promotion 
of liver regeneration can benefit from the in vitro 
expansion of intrahepatic and extrahepatic SPCs, 
specific and safe genetic modifications aiming at these 
SPCs may become feasible and helpful. Once these 
SPCs are well modified, they can more actively 
involve in liver regeneration. Shortly, as the roles of 
cell therapies in promoting liver regeneration are 
gradually better understood, these therapeutic 
approaches will be refined and new pharmacological 
agents for liver repair will be developed. 
Nevertheless, several confronted challenges of cell 
therapy should be taken into consideration or 
discovered in the future, such as how to design a 
precise scheme of cell therapy based the conditions of 
patients, how to evaluate the effecacy of cell therapy, 
how to avoid possible side effects of cell therapy, and 
so on. In brief, our review may serve as a primary 
guidence for the development of regenerative 
strategies using SPCs during liver regeneration. 
Clinical importance in liver diseases 
Once we illuminate the mechanisms of SPCs 
mediated liver regeneration, it has very promising 
cilinical application in treating kinds of human liver 
diseases. First, for cell therapy SPCs could serve as an 
alternative treatment or brigde strategy for liver 
transplantation, especially when the donor is lack. 
Second, activation of endogenous SPCs is not only 
necessary to reserve sufficient liver function before 
extreme volume liver resection, but also efficient to 
restore damaged liver function after severe liver 
trama. Third, it is possible to modify liver cells under 
metabolic liver diseases. In detail, we can isolate SPCs 
from a patient who has liver disease, correct them 
using gene modificatin, expand them in culture, and 
transplant them back to the patient. Last, with the 
help of tissue engineering techniques, it is relatively 
far but very promising to rebuild a whole liver with 
normal function when combination of SPCs with 
decellularized liver scaffold. In the future, if the 
normally functional liver could be produced, we 
would have more chances to treat end-stage liver 
diseases.  
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